Table 2.
Association between gout and HRQOL in peritoneal dialysis
| Outcome | Overall Mean | Among Gout | Among No-Gout | Effect | 95% CI |
|---|---|---|---|---|---|
| PCS | 37.5 | 37.4 | 37.5 | −0.7 | −2.3 to 0.9 |
| MCS | 49.0 | 48.7 | 49.3 | −0.6 | −2.2 to 1.1 |
| Kidney disease burden | 54.7 | 55.2 | 54.3 | −0.8 | −5.8 to 4.2 |
| Kidney disease effects | 72.8 | 73.4 | 72.3 | 1.0 | −2.2 to 4.2 |
| Kidney disease symptoms | 78.0 | 77.9 | 78.1 | −0.4 | −2.6 to 1.8 |
Adjusted difference between gout and non-gout patients (Gout3). Propensity score models adjusted for study phase, EHR data source, demographics, including patient age, sex, Black race, BMI, and dialysis vintage, 13 comorbidities, albumin, creatinine, phosphorus, and vascular access type. HRQOL, health-related quality of life; CI, confidence interval; PCS, physical component summary; MCS, mental component summary EHR, electronic health record; BMI, body mass index.